T 1418/22 (ACERTA PHARMA / ACALABRUTINIB POLYMORPHIC FORM) of 19.11.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T141822.20241119
- Date of decision
- 19 November 2024
- Case number
- T 1418/22
- Petition for review of
- -
- Application number
- 16735945.4
- IPC class
- A61K 31/4985C07D 487/04A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE
- Applicant name
- Acerta Pharma B.V.
- Opponent name
- Kraus & Lederer PartGmbB
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Inventive step - (yes)
Late-filed evidence - admitted (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.